1. Welcome!Whats New in Colorectal Cancer Research?Part of Fight Colorectal Cancer’s Monthly Patient Webinar Series Our webinar will begin shortlywww.FightColorectalCancer.orgwww.CCAlliance.org877-427-2111…

Slide 1 Keynote lecture 5: Priorities for clinical research in GI cancer Daniel G. Haller, MD Professor of Medicine Abramson Cancer Center and the Perelman School of Medicine…

Which difference should we target? Alberto Sobrero Ospedale San Martino IRCCS Genova, Italy Which delta should we target? Delta for deciding GO - NO GO to phase III (signal…

Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV + CT: Results…

Efficacy of FOLFIRI-3 or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study FC Bidard (1), C Tournigand (1),…

Keynote lecture 5: Priorities for clinical research in GI cancer Keynote lecture 5: Priorities for clinical research in GI cancer Daniel G. Haller, MD Professor of Medicine…